Trending

MultiMetaVerse Plans to Acquire Equity Stake in Taomee June 2, 2023

Janssen to Move forward with Clinical Development of LAVA Therapeutics’s Lead Gamma-Delta T-Cell Engager Bispecific Antibody June 2, 2023

Autolus Therapeutics to Present Positive Results from its Phase 2 FELIX study in adult r/r B-ALL at ASCO June 2, 2023

Connect Biopharma Higher on Positive Phase 2 Icanbelimod Trial Data June 2, 2023

Monopar Reports Positive Camsirubicin Phase 1b Trial Update June 1, 2023

Next

Prev

$399.29 $4.25 1.05%

$179.21 $0.37 0.21%

$126.61 $1.31 1.05%

$221.31 $3.70 1.70%

$127.91 $1.28 1.01%

Symbol: OTCQX:NUPMF

Venture Breakfast Bits, by 24/7 Market News

October 11, 2019

DENVER, Colo., October 11, 2019- (24/7MarketNews via COMTEX) Venture Market News for October 11, 2019. Emmaus Life Sciences Reports Preliminary ...